Amlodipin/valsartan/hidroklorotiazid Genepharm 5 mg/160 mg/12,5 mg filmom obložene tablete Korasia - Kroeshia - HALMED (Agencija za lijekove i medicinske proizvode)

amlodipin/valsartan/hidroklorotiazid genepharm 5 mg/160 mg/12,5 mg filmom obložene tablete

genepharm s.a., 18th km. marathonos ave., pallini attiki, grčka - amlodipinbesilat valsartan hidroklorotiazid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 12,5 mg hidroklorotiazida

Amlodipin/valsartan/hidroklorotiazid Genepharm 10 mg/160 mg/25 mg filmom obložene tablete Korasia - Kroeshia - HALMED (Agencija za lijekove i medicinske proizvode)

amlodipin/valsartan/hidroklorotiazid genepharm 10 mg/160 mg/25 mg filmom obložene tablete

genepharm s.a., 18th km. marathonos ave., pallini attiki, grčka - amlodipinbesilat valsartan hidroklorotiazid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 25 mg hidroklorotiazida

Amlodipin/valsartan/hidroklorotiazid Genepharm 10 mg/160 mg/12,5 mg filmom obložene tablete Korasia - Kroeshia - HALMED (Agencija za lijekove i medicinske proizvode)

amlodipin/valsartan/hidroklorotiazid genepharm 10 mg/160 mg/12,5 mg filmom obložene tablete

genepharm s.a., 18th km. marathonos ave., pallini attiki, grčka - amlodipinbesilat valsartan hidroklorotiazid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 12,5 mg hidroklorotiazida

Amlodipin/valsartan/hidroklorotiazid Genepharm 10 mg/320 mg/25 mg filmom obložene tablete Korasia - Kroeshia - HALMED (Agencija za lijekove i medicinske proizvode)

amlodipin/valsartan/hidroklorotiazid genepharm 10 mg/320 mg/25 mg filmom obložene tablete

genepharm s.a., 18th km. marathonos ave., pallini attiki, grčka - amlodipinbesilat valsartan hidroklorotiazid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata), 320 mg valsartana i 25 mg hidroklorotiazida

Amlodipin/valsartan/hidroklorotiazid Genepharm 5 mg/160 mg/25 mg filmom obložene tablete Korasia - Kroeshia - HALMED (Agencija za lijekove i medicinske proizvode)

amlodipin/valsartan/hidroklorotiazid genepharm 5 mg/160 mg/25 mg filmom obložene tablete

genepharm s.a., 18th km. marathonos ave., pallini attiki, grčka - amlodipinbesilat valsartan hidroklorotiazid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 25 mg hidroklorotiazida

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Eucreas Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

eucreas

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Nevanac Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

nevanac

novartis europharm limited - nepafenaka - pain, postoperative; ophthalmologic surgical procedures - ophthalmologicals - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Galvus Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Jalra Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - dijabetes mellitus, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).